Metro Infusion Center
Welcome to Metro Infusion Center, a premier health and wellness facility located in the heart of Phoenix. Specializing in a comprehensive range of infusion therapies, this center offers state-of-the-art treatments tailored to meet the unique needs of each patient. With a focus on Antibody Testing and advanced Immunotherapy options, including Rituximab and Pembrolizumab, patients can trust that they are receiving the highest standard of care.
Metro Infusion Center is renowned for its Chemotherapy administration, adhering strictly to the guidelines set by the American Society of Clinical Oncology and other leading organizations. This commitment to safety and excellence ensures that patients receive effective treatment in a supportive environment.
In addition to cancer care, the center provides innovative Biologically Derived Therapies and Hormone Therapy, utilizing advanced medications such as Leuprolide Acetate to address hormone-related conditions. Their diverse IV Therapy options, including IVIG and IV Vitamin Drips, are designed to boost immune function and enhance overall well-being.
Unique to Metro Infusion Center is their focus on financial accessibility, offering Financial Assistance Programs to qualifying patients, ensuring that all individuals can receive the care they need.
With a compassionate team led by experienced professionals, Metro Infusion Center invites you to explore their extensive range of therapeutic services. Experience the difference in your health journey at this trusted Phoenix facility, where personalized care meets innovative treatment solutions.
Service Filters
Services Offered
Monoclonal Antibody Treatment
Price: Price not available
Biotherapy
Price: Price not available
Bevacizumab
Price: Price not available
Chemotherapy
Price: Price not available
Financial Assistance Programs
Price: Price not available
Leuprolide Acetate
Price: Price not available
Rituximab
Price: Price not available
Immunotherapy
Price: Price not available
Atezolizumab
Price: Price not available